Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Income towards Parent Company (2022 - 2025)

TriSalus Life Sciences' Income towards Parent Company history spans 4 years, with the latest figure at -$9.8 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company rose 3.51% year-over-year to -$9.8 million; the TTM value through Dec 2025 reached -$39.2 million, down 30.56%, while the annual FY2025 figure was -$39.2 million, 30.56% down from the prior year.
  • Income towards Parent Company reached -$9.8 million in Q4 2025 per TLSIW's latest filing, up from -$10.8 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $2.8 million in Q1 2022 to a low of -$35.6 million in Q4 2023.
  • Average Income towards Parent Company over 4 years is -$9.6 million, with a median of -$9.0 million recorded in 2025.
  • The largest YoY upside for Income towards Parent Company was 82.39% in 2023 against a maximum downside of 685.61% in 2023.
  • A 4-year view of Income towards Parent Company shows it stood at -$22.5 million in 2022, then tumbled by 58.1% to -$35.6 million in 2023, then surged by 71.64% to -$10.1 million in 2024, then rose by 3.51% to -$9.8 million in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Income towards Parent Company are -$9.8 million (Q4 2025), -$10.8 million (Q3 2025), and -$8.3 million (Q2 2025).